Deutsche Bank’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.07M Sell
620,446
-64,700
-9% -$111K ﹤0.01% 2044
2025
Q1
$2.28M Sell
685,146
-182,430
-21% -$607K ﹤0.01% 1651
2024
Q4
$6.42M Buy
867,576
+112,095
+15% +$830K ﹤0.01% 1202
2024
Q3
$7.09M Buy
755,481
+41,114
+6% +$386K ﹤0.01% 1129
2024
Q2
$5.73M Sell
714,367
-9,299
-1% -$74.6K ﹤0.01% 1183
2024
Q1
$10.7M Sell
723,666
-1,191,746
-62% -$17.7M 0.01% 989
2023
Q4
$15.6M Buy
1,915,412
+1,412,125
+281% +$11.5M 0.01% 855
2023
Q3
$2.29M Sell
503,287
-2,808,693
-85% -$12.8M ﹤0.01% 1293
2023
Q2
$23.3M Buy
3,311,980
+2,387,330
+258% +$16.8M 0.01% 728
2023
Q1
$5.65M Buy
924,650
+168,657
+22% +$1.03M ﹤0.01% 1192
2022
Q4
$4.83M Buy
755,993
+5,797
+0.8% +$37K ﹤0.01% 1228
2022
Q3
$7.19M Buy
750,196
+35,456
+5% +$340K ﹤0.01% 1083
2022
Q2
$7.89M Buy
714,740
+582,048
+439% +$6.43M ﹤0.01% 1090
2022
Q1
$2.21M Buy
132,692
+47,502
+56% +$791K ﹤0.01% 1820
2021
Q4
$1.63M Sell
85,190
-23,487
-22% -$448K ﹤0.01% 2104
2021
Q3
$2.68M Buy
108,677
+101,473
+1,409% +$2.5M ﹤0.01% 1880
2021
Q2
$188K Sell
7,204
-4,411,080
-100% -$115M ﹤0.01% 3781
2021
Q1
$140M Buy
4,418,284
+4,357,108
+7,122% +$138M 0.08% 261
2020
Q4
$2.84M Sell
61,176
-252
-0.4% -$11.7K ﹤0.01% 1676
2020
Q3
$2.02M Sell
61,428
-21,774
-26% -$717K ﹤0.01% 1731
2020
Q2
$2.28M Sell
83,202
-193,055
-70% -$5.3M ﹤0.01% 1709
2020
Q1
$8.27M Buy
276,257
+27,935
+11% +$836K 0.01% 987
2019
Q4
$6.87M Sell
248,322
-28,423
-10% -$787K ﹤0.01% 1272
2019
Q3
$5.04M Buy
276,745
+205,279
+287% +$3.74M ﹤0.01% 1400
2019
Q2
$1.75M Buy
71,466
+786
+1% +$19.2K ﹤0.01% 2473
2019
Q1
$670K Sell
70,680
-3,014
-4% -$28.6K ﹤0.01% 3230
2018
Q4
$651K Sell
73,694
-318,087
-81% -$2.81M ﹤0.01% 3126
2018
Q3
$4.41M Buy
391,781
+164,729
+73% +$1.85M ﹤0.01% 2279
2018
Q2
$2.91M Buy
227,052
+66,245
+41% +$848K ﹤0.01% 2687
2018
Q1
$2.72M Buy
160,807
+20,271
+14% +$342K ﹤0.01% 2655
2017
Q4
$1.12M Buy
140,536
+3,627
+3% +$29K ﹤0.01% 3077
2017
Q3
$1.06M Buy
136,909
+74,817
+120% +$579K ﹤0.01% 2923
2017
Q2
$456K Buy
62,092
+39,201
+171% +$288K ﹤0.01% 3412
2017
Q1
$169K Sell
22,891
-20,023
-47% -$148K ﹤0.01% 3523
2016
Q4
$297K Buy
42,914
+220
+0.5% +$1.52K ﹤0.01% 3357
2016
Q3
$350K Buy
42,694
+12,811
+43% +$105K ﹤0.01% 3271
2016
Q2
$240K Buy
29,883
+23,039
+337% +$185K ﹤0.01% 3567
2016
Q1
$34K Sell
6,844
-13,569
-66% -$67.4K ﹤0.01% 4174
2015
Q4
$156K Sell
20,413
-1,327
-6% -$10.1K ﹤0.01% 3678
2015
Q3
$123K Buy
21,740
+1,720
+9% +$9.73K ﹤0.01% 3828
2015
Q2
$183K Sell
20,020
-2,980
-13% -$27.2K ﹤0.01% 3765
2015
Q1
$278K Buy
+23,000
New +$278K ﹤0.01% 3496